In vivo antitumoral activity of 5-(N-carbobenzyloxyamino)-1,4-naphthoquinone.
Riondel
J
J
Laboratoire de Physiologie et Pharmacologie, Faculté de Pharmacie de Grenoble, France.
Jacrot
M
M
Beriel
H
H
Chigr
M
M
Fillion
H
H
D000236:Adenoma / Q000188:drug therapy; D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D003537:Cystadenoma / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D051379:Mice; D008815:Mice, Inbred Strains; D009285:Naphthoquinones / Q000138:chemical synthesis* / Q000494:pharmacology; D009368:Neoplasm Transplantation; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology
D000970:Antineoplastic Agents; D009285:Naphthoquinones; C069892:5-(N-carbobenzyloxyamino)-1,4-naphthoquinone